Par Pharmaceutical(PRX)
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Amiodarone | Amiodarone | 2003-04-25 | 2029 | |
| Amitriptyline | Amitriptyline | 1984-09-25 | ||
| Antizol | Fomepizole | 1997-12-04 | 2027 | |
| Brompheniramine | Brompheniramine | 1982-01-01 | ||
| Chlorpropamide | Chlorpropamide | 1984-02-27 | ||
| Clonidine | Clonidine | 1986-07-08 | 2027-2031 | |
| Clonidine chlorthalidone | Clonidine, Chlorthalidone | 1987-12-16 | 2027-2031 |
1
2
3
4
5
6
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use